
- An extended reproductive life span, notably later menopause, was related to fewer indicators of small-vessel illness within the mind, together with roughly 8% decrease odds of getting a number of illness markers.
- Menopausal hormone remedy (MHT) was related to fewer indicators of small-vessel illness and higher white matter integrity, though these associations could range relying on genetic and particular person well being elements.
- Whereas MHT could supply potential mind well being advantages when began round menopause, it has not been confirmed to stop Alzheimer’s illness or dementia.
Girls who’ve longer reproductive life spans or use menopausal hormone remedy (MHT) could have higher mind well being as they age, in response to a brand new examine.
The analysis, revealed November 4 in Neurology, discovered that longer lifetime publicity to estrogen was related to fewer indicators of harm to small blood vessels within the mind.
The findings may supply new insights into the connection between estrogen and mind growing older, notably as ladies account for about two-thirds of Alzheimer’s illness instances worldwide.
Researchers additionally discovered that sure associations between hormone remedy and mind well being differed relying on whether or not ladies carried a genetic variant related to an elevated danger of Alzheimer’s illness.
Nevertheless, the connection between estrogen and mind well being is complicated. Whereas the findings counsel that longer estrogen publicity could also be related to more healthy mind growing older, they don’t set up that hormone remedy can forestall Alzheimer’s illness or dementia.
The ultimate cohort included 352 cisgender ladies, with a mean age of 70, who had no neurological problems and dependable self-reported information on their estrogen publicity.
Particular person estrogen publicity was measured via structured interviews. It included:
The researchers used this info as a proxy for lifetime estrogen publicity, although the examine didn’t measure precise hormone ranges.
Contributors had been additionally given a mind MRI at baseline after which once more at a 5-year follow-up.
The researchers discovered that these with an extended reproductive span had a decrease danger of small vessel disease (SVD). Contributors with an extended reproductive life span had an 8% decrease danger of getting two or extra indicators of SVD. Nevertheless, later menopause, moderately than earlier menstruation, gave the impression to be the principle driver of this affiliation.
Those that used MHT additionally tended to have fewer indicators of SVD and higher microstructural integrity within the white matter.
In people who carried the APOE-ε4 variant, which will increase an individual’s danger of Alzheimer’s illness, MHT was related to better cortical thickness in mind areas weak to Alzheimer’s illness. Nevertheless, there was no affiliation for these with out this variant.
The researchers famous that longer estrogen publicity was related to steady cortical thickness and white matter trajectories over time.
Dung Trinh, MD, internist at MemorialCare Medical Group and Chief Medical Officer of Wholesome Mind Clinic in Irvine, CA, who wasn’t concerned within the examine, informed Healthline that estrogen has several important effects on the mind that will assist assist cognitive well being.
It influences communication between mind cells, helps the mind’s means to make use of glucose for power, helps regulate neurotransmitters, and performs a job in sustaining wholesome blood vessels and lowering irritation and oxidative stress.
“As estrogen ranges decline throughout menopause, a few of these protecting results could diminish. Changing estrogen nearer to the menopause transition may doubtlessly assist protect a few of these capabilities throughout a weak interval for mind well being,” he stated. “Whereas these findings are encouraging, MHT has not been confirmed to stop Alzheimer’s illness or dementia.”
Sherry Ross, MD, board licensed OB/GYN and Girls’s Well being Skilled at Windfall Saint John’s Well being Middle in Santa Monica, CA, who additionally wasn’t concerned within the examine, agreed and famous, “Beginning menopausal hormone remedy earlier within the menopause transition could assist decrease some modifications by supporting the mind throughout this era of hormonal fluctuation.”
“There’s rising curiosity in whether or not early estrogen remedy might also assist cut back the long-term danger of Alzheimer’s disease, though extra analysis is required earlier than we will set up that profit,” she added.
Ross informed Healthline that this analysis reinforces the significance of recognizing menopause as greater than a reproductive or hormonal transition.
“We all know that ladies are disproportionately affected by dementia and Alzheimer’s illness, and a few ladies expertise noticeable cognitive modifications starting in perimenopause,” she stated. “If future analysis confirms that beginning hormone remedy earlier may also help shield long-term cognitive well being, it may affect how we method menopause therapy and encourage extra proactive conversations between ladies and their healthcare suppliers.”
“The purpose ought to be to individualize therapy primarily based on a lady’s signs, medical historical past, and total well being moderately than taking a one-size-fits-all method,” Ross added.
Trinh agreed that an individualized method to menopause administration is essential.
“This doesn’t imply that each girl ought to begin hormone remedy to stop dementia. As an alternative, it highlights the significance of understanding which ladies would possibly profit, when therapy ought to start, and which formulations are most acceptable,” he stated. “Elements resembling age, time since menopause, cardiovascular danger, metabolic well being, household historical past, and doubtlessly genetic elements could all assist information future suggestions.”
“We nonetheless want stronger scientific proof earlier than altering present prescribing pointers particularly for dementia prevention,” Trinh added.
